Evaluating Day +90 Donor Chimerism as a Prognostic Marker of Clinical Outcomes Among Allogeneic Hematopoietic Cell Transplant Recipients Who Received Myeloablative Conditioning
Authors:
- Sara JubasSJSara Jubas
- Kieran CollinsKCKieran Collins
- Kendall ObaraKOKendall Obara
- Hsuan-Hui (Grace) LiuHLHsuan-Hui (Grace) Liu
- Ryan M. KemperRKRyan M. Kemper
- Alexandra L.W. KelleyAKAlexandra L.W. Kelley
- Arushi GoelAGArushi Goel
- Tyler C. DunlapTDTyler C. Dunlap
- Jing ZhuJZJing Zhu
- Riley M. RandolphRRRiley M. Randolph
- Jonathan R. PtachcinskiJPJonathan R. Ptachcinski
- Morgan E. BizzellMBMorgan E. Bizzell
- 18 June 2026
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (10) , 1299.e1-1299.e15
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences
- National Cancer Institute
This publication has 45 references indexed in Scilit:
- A practical guide to chimerism analysis: Review of the literature and testing practices worldwideHuman Immunology, 2021
- Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2019
- Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic DosingTransplantation and Cellular Therapy, 2016
- Early Donor Chimerism Levels Predict Relapse and Survival after Allogeneic Stem Cell Transplantation with Reduced-Intensity ConditioningTransplantation and Cellular Therapy, 2014
- Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic LeukemiaTransplantation and Cellular Therapy, 2014
- Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and SurvivalTransplantation and Cellular Therapy, 2014
- Establishing a Target Exposure for Once-Daily Intravenous Busulfan Given with Fludarabine and Thymoglobulin before Allogeneic TransplantationTransplantation and Cellular Therapy, 2013
- Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303Transplantation and Cellular Therapy, 2011
- Defining the Intensity of Conditioning Regimens: Working DefinitionsTransplantation and Cellular Therapy, 2009
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948